(2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor-Reference-Cited by-同舟云学术

(2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor

Published:2011-03 Issue:1-3 Volume:655 Page:99-107
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Tajima Atsushi,Yamamoto Koji,Kozakai Akinori,Okumura-Kitajima Lisa,Mita Yasuo,Kitano Kiyokazu,Jingu Shigeji,Nakaike Shiro

Publisher

Elsevier BV

Subject

Pharmacology

Reference35 articles.

1. Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus;Ahrén;J. Clin. Endocrinol. Metab.,1997

2. Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice;Ahrén;Eur J Pharmacol.,2000

3. Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes;Ahrén;Diab. Care,2002

4. Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes;Ahrén;Diab. Care,2004

5. Inhibition of human elastase from polymorphonuclear leucocytes by gold sodium thiomalate and pentosan polysulfate (SP-54);Baici;Biochem. Pharmacol.,1981

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Medicinal Chemistry Approach for the Development of Dipeptidyl Peptidase IV Inhibitors;Current Medicinal Chemistry;2021-06-10

2. Copper-catalyzed [3 + 2]-cycloaddition of α-halonitroalkenes with azomethine ylides: facile synthesis of multisubstituted pyrrolidines and pyrroles;Organic & Biomolecular Chemistry;2021

3. CMD-05, a novel promising clinical anti-diabetic drug candidate, in vivo and vitro studies;Scientific Reports;2017-04-13

4. Sixteen-Years of Clinically Relevant Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors for Treatment of Type-2 Diabetes: A Perspective;Current Medicinal Chemistry;2014-10-23

5. Combination of TS-021 with metformin improves hyperglycemia and synergistically increases pancreatic β-cell mass in a mouse model of type 2 diabetes;Life Sciences;2011-10